This work was presented in abstract form at the conference “New Challenges in Tropical Medicine and Parasitology”, 18–22 September 2000, Oxford, UK.
Prevalence of Anti-poliovirus Type 1, 2 and 3 Antibodies in Unvaccinated Italian Travelers
Version of Record online: 8 MAR 2006
Journal of Travel Medicine
Volume 11, Issue 1, pages 34–36, January 2004
How to Cite
Signorini, L., Barbi, M., Matteelli, A., Binda, S., Didò, P., Caroppo, S., Primache, V., Pisani, S., Messino, C., Brunelli, M., Costa, P., Ronca, E., Fausti, C. and Castelli, F. (2004), Prevalence of Anti-poliovirus Type 1, 2 and 3 Antibodies in Unvaccinated Italian Travelers. Journal of Travel Medicine, 11: 34–36. doi: 10.2310/7060.2004.13651
Pasteur BioMerieux provided financial support for the laboratory investigations presented in this study.
Apart from this, the authors had no financial or other conflicts of interest to disclose.
- Issue online: 8 MAR 2006
- Version of Record online: 8 MAR 2006
- 2World Health Organization. International travel and health. Vaccine preventable diseases. Poliomyelitis 12 September 2003. http://www.who.int/ith/chapter06_07.html.
- 3Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000; 49 (RR-5): 122 Anonymous.
- 6World Health Organization. Guidelines for WHO/EPI collaborative studies on poliomyelitis. Standard procedure for determining immunity to poliovirus using the microneutralization test. WHO/EPI/GEN/93.9 1993 Geneva World Health Organization.
- 8Certification of poliomyelitis eradication—Western Pacific Region, October 2000. MMWR 2001; 50: 1–3 Anonymous. AMBIGUOUS (23 citations)
- 9World Health Organization. Mediacentre. Europe on track to be certified polio free on 21 June 2002 12 September 2003. http://www.who.int/multimedia/polio2002.
- 15Vaccination status and illnesses in foreign travelers. Gesundheitswesen 1999; 61 (Suppl): S106–S109., , .